Gilead Sciences Aktie
91,76
EUR
-1,76
EUR
-1,88
%
104,89
USD
-0,77
USD
-0,73
%
Werbung
Gilead Sciences Aktie Analyse
| 06.10.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 06.10.11 | Gilead Sciences halten | Der Aktionär | |
| 21.09.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 19.09.11 | Gilead Sciences buy | UBS AG | |
| 07.09.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 30.08.11 | Gilead Sciences hold | Citigroup Corp. | |
| 24.08.11 | Gilead Sciences hold | Citigroup Corp. | |
| 23.08.11 | Gilead Sciences outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 17.08.11 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 17.08.11 | Gilead Sciences buy | Deutsche Bank Securities | |
| 11.08.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 27.07.11 | Gilead Sciences buy | UBS AG | |
| 30.06.11 | Gilead Sciences overweight | Piper Jaffray & Co. | |
| 17.05.11 | Gilead Sciences hold | Citigroup Corp. | |
| 21.04.11 | Gilead Sciences outperform | Credit Suisse Group | |
| 18.04.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 23.03.11 | Gilead Sciences buy | UBS AG | |
| 17.03.11 | Gilead Sciences kaufen | Der Aktionär | |
| 11.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 01.03.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 24.02.11 | Gilead Sciences outperform | RBC Capital Markets | |
| 18.02.11 | Gilead Sciences kaufen | Der Aktionär | |
| 27.01.11 | Gilead Sciences equal-weight | Barclays Capital | |
| 26.01.11 | Gilead Sciences outperform | Credit Suisse Group | |
| 20.01.11 | Gilead Sciences outperform | Credit Suisse Group | |
| 10.01.11 | Gilead Sciences hold | Citigroup Corp. | |
| 06.01.11 | Gilead Sciences outperform | Williams Capital | |
| 07.12.10 | Gilead Sciences outperform | Credit Suisse Group | |
| 17.11.10 | Gilead Sciences buy | UBS AG | |
| 08.11.10 | Gilead Sciences equal-weight | Barclays Capital | |
| 01.11.10 | Gilead Sciences outperform | RBC Capital Markets | |
| 15.09.10 | Gilead Sciences equal-weight | Barclays Capital | |
| 09.09.10 | Gilead Sciences hold | Stifel, Nicolaus & Co., Inc. | |
| 22.07.10 | Gilead Sciences sector perform | RBC Capital Markets | |
| 21.07.10 | Gilead Sciences outperform | Oppenheimer & Co. Inc. | |
| 25.06.10 | Gilead Sciences verkaufen | Der Aktionär | |
| 04.06.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
| 04.05.10 | Gilead Sciences kaufen | Morgan Stanley | |
| 23.04.10 | Gilead Sciences kaufen | Morgan Stanley | |
| 22.04.10 | Gilead Sciences halten | Jefferies & Company Inc. | |
| 21.04.10 | Gilead Sciences kaufen | Needham & Company, LLC | |
| 01.04.10 | Gilead Sciences kaufen | Der Aktionär | |
| 12.03.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
| 16.02.10 | Gilead Sciences kaufen | Credit Suisse Group | |
| 29.01.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
| 27.01.10 | Gilead Sciences kaufen | Credit Suisse Group | |
| 18.12.09 | Gilead Sciences hold | Jefferies & Company Inc. | |
| 15.12.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 11.12.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 02.12.09 | Gilead Sciences buy | UBS AG | |
Werbung
Werbung